The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa: a systematic review and meta-analysis

References

• Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, Aboyans V, Adetokunboh O, Afshin A, et al. Global, regional, and national age-sex-specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390:1151–210. doi:10.1016/S0140-6736(17)32152-9.
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS. How AIDS changed everything. MDG 6. Geneva, Switzerland: UNAIDS; 2015.
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. AIDSInfo. 2017 [accessed 2018 June 26]. http://aidsinfo.unaids.org/.
   Google Scholar
• United Nations Children's Fund (UNICEF). The State of the World's Children 2016: A Fair Chance for Every Child. New York, USA. UNICEF; 2016.
   Google Scholar
• Tejiokem MC, Gouandjika I, Béniguel L, Zanga M-CE, Tene G, Gody JC, Njamkepo E, Kfutwah A, Penda I, Bilong C, et al. HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the expanded program on immunization. PLoS One. 2007;2:e1260. doi:10.1371/journal.pone.0001260.
   PubMed Web of Science ®Google Scholar
• Miller MA, Hinman AR. Chapter 72. Economic analyses of vaccine policies. In: Miller MA, Hinman AR, Plotkin SA, Orenstein WA, editors. Vaccines, 1413–1426. Philadelphia, USA: Elsevier Inc.; 2004. 10.1016/b978-1-4557-0090-5.00072-0
   Google Scholar
• Hadler SC, Cochi SL, Bilous J, Cutts FT. Chapter 55. Vaccination programs in developing countries. In: Plotkin SA, Orenstein WA, editors. Vaccines, 1407–1442. Philadelphia, USA: Saunders. 2003.
   Google Scholar
• Tao W, Petzold M, Forsberg BC. Routine vaccination coverage in low- and middle-income countries: further arguments for accelerating support to child vaccination services. Glob Health Action. 2013;6:0–8. doi:10.3402/gha.v6i0.20343.
   Web of Science ®Google Scholar
• Tchidjou HK, Vescio MF, Sanou Sobze M, Souleyman A, Stefanelli P, Mbabia A, Moussa I, Gentile B, Colizzi V, Rezza G. Low vaccine coverage among children born to HIV infected women in Niamey, Niger. Human Vacc Immunoth. 2016;12:540–44. doi:10.1080/21645515.2015.1069451.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Vaccine Action Plan 2011-2020. Geneva, Switzerland: WHO; 2013.
   Google Scholar
• World Health Organization. 2015 Assessment report of the global vaccine action plan. Geneva, Switzerland: WHO; 2016.
   Google Scholar
• World Health Organization. Estimates of disease burden and cost effectiveness. Geneva, Switzerland: WHO; 2017.
   Google Scholar
• World Health Organization. Summary of WHO position papers-recommendations for routine immunization. 2018 [accessed 2018 June 26]. http://www.who.int/immunization/policy/Immunization_routine_table1.pdf?ua=1.
   Google Scholar
• Du Plessis NM, Ntshoe G, Reubenson G, Kularatne R, Blumberg L, Thomas J, Avenant T. Risk factors for pertussis among hospitalized children in a high HIV prevalence setting, South Africa. Int J Infect Dis. 2018;68:54–60. doi:10.1016/j.ijid.2018.01.010.
   PubMed Web of Science ®Google Scholar
• Abuogi LL, Mwachari C, Leslie HH, Shade SB, Otieno J, Yienya N, Sanguli L, Amukoye E, Cohen CR. Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya. Int J Tuberc Lung Dis. 2017;17:1291–97. doi:10.5588/ijtld.12.0740.
   Google Scholar
• L V A, Iii TM, Naburi H, Lyatuu G, Ippolito M, Saunders A, Kiravu A, Palumbo P. Diagnosis and treatment of tuberculosis among children at an HIV care program in Dar es Salaam, Tanzania. Pediatr Inf Dis J. 2015;33:1234–36.
   Web of Science ®Google Scholar
• Alemu YM, Andargie G, Gebeye E, Paraskevis D. High incidence of tuberculosis in the absence of isoniazid and cotrimoxazole preventive therapy in children living with HIV in Northern Ethiopia: a retrospective follow-up study. PLoS One. 2016;11:e0152941. doi:10.1371/journal.pone.0152941.
   PubMed Web of Science ®Google Scholar
• Anígilájé EA, Aderibigbe SA, Adeoti AO, Nweke NO, Adam RD. Tuberculosis before and after antiretroviral therapy among HIV-Infected children in Nigeria: what are the risk factors? PLoS One. 2016;11:e0156177. doi:10.1371/journal.pone.0156177.
   PubMed Web of Science ®Google Scholar
• Auld AF, Tuho MZ, Ekra KA, Kouakou J, Shiraishi RW. Tuberculosis in human immunodeficiency virus-infected d’ Ivoire children starting antiretroviral therapy in Cote D’Ivoire. Int J Tuberc Lung Dis. 2014;18:381–87. doi:10.5588/ijtld.13.0395.
   PubMed Web of Science ®Google Scholar
• Bakeera-Kitaka S, Conesa-Botella A, Dhabangi A, Maganda A, Kekitiinwa A, Colebunders R. Tuberculosis in HIV-infected Ugandan children starting on antiretroviral therapy. Int J Tuberc Lung Dis. 2012;15:1082–86. doi:10.5588/ijtld.10.0538.
   Web of Science ®Google Scholar
• Bonnet M, Kyomugasho N, Kiwanuka J, Kumbakumba E. Outcome of children with presumptive tuberculosis in Mbarara, Rural Uganda. Pediatr Infect Dis J. 2018;37:147–52. doi:10.1097/INF.0000000000001727.
   PubMed Web of Science ®Google Scholar
• Braitstein P, Wools-Kaloustian K, Sidle J, Ayaya S, Carter EJ. The clinical burden of tuberculosis among Human Immunodeficiency Virus-infected children in Western Kenya. Pediatr Infect Dis J. 2009;28:626–32. doi:10.1097/INF.0b013e31819665c5.
   PubMed Web of Science ®Google Scholar
• Buck WC, Olson D, Kabue MM, Ahmed S, Nchama LK, Munthali A, Kazembe PN. Risk factors for mortality in Malawian children with human immunodeficiency virus and tuberculosis co-infection. Int J Tuberc Lung Dis. 2017;17:1389–95. doi:10.5588/ijtld.13.0030.
   Google Scholar
• Carlucci JG, Peratikos MB, Kipp AM, Lindegren ML, Du QT, Renner L, Reubenson G, Ssali J, Yotebieng M, Mandalakas AM, et al. Tuberculosis treatment outcomes among HIV/TB-coinfected children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network. JAIDS J Acquir Immune Defic Syndr. 2017;75:156–63. doi:10.1097/QAI.0000000000001335.
   PubMed Web of Science ®Google Scholar
• Cavanaugh J, Genga K, Marigu I, Laserson K, Ackers M, Cain K. Tuberculosis among children in Kenya: epidemiology and impact of HIV in two Provinces. J Trop Pediatr. 2012;58:292–96. doi:10.1093/tropej/fmr098.
   PubMed Web of Science ®Google Scholar
• Chaya S, Dangor Z, Solomon F, Nzenze SA, Izu A, Madhi SA. Incidence of tuberculosis meningitis in a high HIV prevalence setting: time-series analysis from 2006 to 2011. Int J Tuberc Lung Dis. 2016;20:1457–62. doi:10.5588/ijtld.15.0845.
   PubMed Web of Science ®Google Scholar
• Cruz AT, Marape M, Graviss EA, Starke JR. Performance of the QuantiFERON-TB Gold Interferon Gamma Release Assay among HIV-infected children in Botswana. J Int Assoc Provid AIDS Care. 2015;14:4–7. doi:10.1177/2325957414547432.
   PubMedGoogle Scholar
• Dangor Z, Izu A, Hillier K, Solomon F, Beylis N, Moore DP, Nunes MC, Madhi SA. Impact of the antiretroviral treatment program on the burden of hospitalization for culture-confirmed tuberculosis in South African children. Pediatr Infect Dis J. 2013;32:972–77. doi:10.1097/INF.0b013e31828d9aa4.
   PubMed Web of Science ®Google Scholar
• De MT, Saloojee H. Clinical outcomes of severe malnutrition in a high tuberculosis and HIV setting. Arch Dis Child. 2011;96:560–64. doi:10.1136/adc.2010.205039.
   PubMed Web of Science ®Google Scholar
• Ebonyi AO, Oguche S, Agbaji OO, Sagay AS, Okonkwo PI, Idoko JA, Kanki PJ. Mortality among pulmonary tuberculosis and HIV-1 co-infected Nigerian children being treated for pulmonary tuberculosis and on antiretroviral therapy: a retrospective cohort study. GERMS. 2016;6:139–50. doi:10.11599/issn.2248-2997.
   PubMedGoogle Scholar
• Ebonyi AO, Oguche S, Ejeliogu EU, Agbaji OO, Shehu NY, Abah IO. Prevalence of and risk factors for pulmonary tuberculosis among newly diagnosed HIV-1 infected Nigerian children. GERMS. 2016;6:21–28. doi:10.11599/germs.2016.1085.
   PubMedGoogle Scholar
• Elenga N, Kouakoussui KA, Bonard D, Fassinou P, Wemin M, Dick-Amon-Tanoh F, Msellati P. Diagnosed tuberculosis during the follow-up of a cohort of Human Immunodeficiency Virus-infected children in Abidjan, Cote d’Ivoire. Pediatr Infect Dis J. 2005;24:1077–82. doi:10.1097/01.inf.0000190008.91534.b7.
   PubMed Web of Science ®Google Scholar
• Ferrand RA, Bandason T, Musvaire P, Larke N, Nathoo K, Mujuru H, Ndhlovu CE, Munyati S, Cowan FM, Gibb DM, et al. Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey. PLoS Med. 2010;7:e1000178. doi:10.1371/journal.pmed.1000178.
   PubMed Web of Science ®Google Scholar
• Hall EW, Morris SB, Moore BK, Erasmus L. Treatment outcomes of children with HIV infection and drug-resistant TB in three provinces. Pediatr Infect Dis J. 2017;36:2005–08. doi:10.1097/INF.0000000000001691.
   Web of Science ®Google Scholar
• Hesseling AC, Johnson LF, Jaspan H, Cotton MF, Whitelaw A, Schaaf HS, Fine PEM, Eley BS, Marais BJ. Disseminated bacille Calmette – guérin disease in HIV-infected South African infants. Bull World Health Organ. 2009;87:505–11. doi:10.2471/BLT.08.055657.
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Westra AE, Werschkull H, Donald PR, Beyers N, Hussey GD, El-Sadr W, Schaaf HS. Outcome of HIV infected children with culture confirmed tuberculosis. Arch Dis Child. 2005;90:1171–74. doi:10.1136/adc.2004.070466.
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, Gie RP, Cotton MF, van Helden PD, Warren RM, et al. Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Inf Dis. 2006;42:548–58. doi:10.1086/499953.
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Cotton MF, Jennings T, Whitelaw A, Johnson LF, Eley B, Roux P, Schaaf HS. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population- based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis. 2009;48:108–14. doi:10.1086/595012.
   PubMed Web of Science ®Google Scholar
• Hicks RM, Padayatchi N, Shah NS, Wolf A, Werner L, Sunkari VB, O’Donnell MR. Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children. Int J Tuberc Lung Dis. 2014;18:1074–83. doi:10.5588/ijtld.14.0231.
   PubMed Web of Science ®Google Scholar
• Jeena PM, Coovadia HM, Hadley LG, Wiersma R, Grant H, Chrystal V. Lymph node biopsies in HIV-infected and non-infected children with persistent lung disease. Int J Tuberc Lung Dis. 2000;4:139–46.
   PubMed Web of Science ®Google Scholar
• Kasambira TS, Shah M, Adrian PV, Holshouser M, Madhi SA, Chaisson RE, Martinson NA, Dorman SE. QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact. Int J Tuberc Lung Dis. 2011;15:628–34. doi:10.5588/ijtld.10.0555.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Huebner RE, Doedens L, Aduc T, Wesley D, Cooper PA. HIV-1 co-infection in children hospitalized with tuberculosis in South Africa. Int J Tuberc Lung Dis. 2000;4:448–54.
   PubMed Web of Science ®Google Scholar
• Meyers TM, Pettifor JM, Gray GE, Crewe-Brown H, Galpin JS. Pediatric admissions with human immunodeficiency virus infection at a regional hospital in Soweto, South Africa. J Trop Pediatr. 2000;46:224–30. doi:10.1093/tropej/46.4.224.
   PubMed Web of Science ®Google Scholar
• Mwangwa F, Chamie G, Kwarisiima D, Ayieko J, Owaraganise A, Ruel TD, Plenty A, Tram KH, Clark TD, Cohen CR, et al. Gaps in the child tuberculosis care cascade in 32 rural communities in Uganda and Kenya. J Clin Tuberc Mycobact Dis. 2017;9:24–29.
   PubMedGoogle Scholar
• Obiagwu PN, Hassan-Hanga F, Ibrahim M. Pediatric HIV in Kano, Nigeria. Niger J Clin Pract. 2013;16:521–25. doi:10.4103/1119-3077.116905.
   PubMed Web of Science ®Google Scholar
• Okechukwu AA. Discharge against medical advice in children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria. Niger J Clin Pract. 2011;2:49–54.
   Google Scholar
• Osman M, Lee K, Du Preez K, Dunbar R, Hesseling AC, Seddon JA. Excellent treatment outcomes in children treated for tuberculosis under routine operational conditions in Cape Town, South Africa. Clin Inf Dis. 2017;65:1444–52. doi:10.1093/cid/cix602.
   PubMed Web of Science ®Google Scholar
• Padayatchi N, Bamber S, Dawood H, Bobat R. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa. Pediatr Inf Dis J. 2006;25:147–50. doi:10.1097/01.inf.0000199314.88063.4c.
   PubMed Web of Science ®Google Scholar
• Palme IB, Gudetta B, Bruchfeld J, Muhe L, Giesecke J. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Inf Dis J. 2002;21:1053–61. doi:10.1097/00006454-200211000-00016.
   PubMed Web of Science ®Google Scholar
• Patel MR, Yotebieng M, Behets F, Vanden Driessche K, Nana M, Van Rie A. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level. Int J Tuberc Lung Dis. 2013;17:1206–11. doi:10.5588/ijtld.12.0074-e.
   PubMed Web of Science ®Google Scholar
• Robinson A, Donald PR, Schaaf HS. Nosocomial infections in HIV-infected and HIV-uninfected children hospitalised for tuberculosis. S Afr Fam Pract. 2007;49:14.
   Google Scholar
• Rose MV, Kimaro G, Nissen TN, Kroidl I, Hoelscher M, Bygbjerg IC, Mfinanga SG, Ravn P. Quantiferon®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. PLoS One. 2012;7:1–10. doi:10.1371/journal.pone.0037851.
   Web of Science ®Google Scholar
• Simon HS, Marais BJ, Whitelaw A, Hesseling AC, Eley B, Hussey GD, Donald PR. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Inf Dis. 2007;7:2–9.
   PubMed Web of Science ®Google Scholar
• Soeters M, de Vries AM, Kimpen JL, Donald PR, Schaaf HS. Clinical features and outcome in children admitted to a TB hospital in the Western Cape – the influence of HIV infection and drug resistance. SAMJ. 2005;95:602–06.
   PubMed Web of Science ®Google Scholar
• Walters E, Duvenhage J, Draper HR, Hesseling AC, Van Wyk SS, Cotton MF, Rabie H. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age. Archives Dis Childhood. 2014;99:998–1003. doi:10.1136/archdischild-2013-305509.
   PubMed Web of Science ®Google Scholar
• Walters E, Cotton MF, Rabie H, Schaaf HS, Walters LO, Marais BJ. Clinical presentation and outcome of tuberculosis in Human Immunodeficiency Virus infected children on anti-retroviral therapy. BMC Pediatr. 2008;8:1. doi:10.1186/1471-2431-8-1.
   PubMed Web of Science ®Google Scholar
• Westerlund E, Jerene D, Mulissa Z, Hallstrã¶M I, Lindtjã¸Rn B. Pre-ART retention in care and prevalence of tuberculosis among HIV-infected children at a district hospital in southern Ethiopia. BMC Pediatr. 2014;14:1–9. doi:10.1186/1471-2431-14-82.
   PubMed Web of Science ®Google Scholar
• Wiseman CA, Schaaf HS, Cotton MF, Gie RP, Jennings T, Whitelaw A, Roux P, Hesseling AC. Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival. Int J Tuberc Lung Dis. 2011;15:770–75. doi:10.5588/ijtld.10.0501.
   PubMed Web of Science ®Google Scholar
• Yotebieng M, Van Rie A, Moultrie H, Cole SR, Adimora A, Behets F, Meyers T. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS. 2010;24:1341–49. doi:10.1097/QAD.0b013e328339e576.
   PubMed Web of Science ®Google Scholar
• Kouakoussui A, Fassinou P, Anaky MF, Elenga N, Laguide R, Wemin ML, Toure R, Menan H, Rouet F, Msellati P. Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast. Paediatr Respir Rev. 2004;5:311–15. doi:10.1016/j.prrv.2004.07.008.
   PubMedGoogle Scholar
• Abera B, Zenebe Y, Mulu W, Kibret M, Kahsu G. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot Referral Hospital, Ethiopia. BMC Res Notes. 2014;7:838. doi:10.1186/1756-0500-7-838.
   PubMedGoogle Scholar
• Ashir GM, Rabasa AI, Gofama MM, Bukbuk D, Abubakar H, Farouk GA. Study of hepatic functions and prevalence of hepatitis B surface antigenaemia in Nigerian children with human immunodeficiency virus infection. Nigerian J Med. 2009;18:260–62.
   PubMedGoogle Scholar
• Beghin J-C, Ruelle J, Sokal E, Bachy A, Krishna M, Hall L, Goubau P, Van der Linden D. Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal. J Med Virol. 2017;89:182–85. doi:10.1002/jmv.v89.1.
   PubMed Web of Science ®Google Scholar
• Chotun N, Nel E, Cotton MF, Preiser W, Andersson MI. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. Vaccine. 2015;33:4618–22. doi:10.1016/j.vaccine.2015.06.076.
   PubMed Web of Science ®Google Scholar
• Davidson UN, Chidiebele NI, Josephine EI, Olakunle E, Nnaemeka IA, Chijioke EJ, Kingsley NI. The prevalence of liver function and immunologic status of children with HIV and hepatitis B virus coinfection in Enugu, Nigeria. Afr J Infect Dis. 2016;10:61–68.
   PubMedGoogle Scholar
• Dziuban EJ, Marton SA, Hughey AB, Mbingo TL, Draper HR, Schutze GE. Seroprevalence of hepatitis B in a cohort of HIV-infected children and adults in Swaziland. Int J STDs AIDS. 2013;24:561–65. doi:10.1177/0956462413476274.
   PubMed Web of Science ®Google Scholar
• Ikpeme EE, Etukudo OM. Seroprevalence of HBV and HIV co-infection in children and outcomes following highly active antiretroviral therapy (HAART) in Uyo, South-South Nigeria. Afr Health Sci. 2013;13:955–61. doi:10.4314/ahs.v13i4.14.
   PubMed Web of Science ®Google Scholar
• Jooste P, Van Zyl A, Adland E, Daniels S, Hattingh L, Brits A, Wareing S, Goedhals D, Jeffery K, Andersson M, et al. Screening, characterisation and prevention of hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa. J Clin Virol. 2016;85:71–74. doi:10.1016/j.jcv.2016.10.017.
   PubMed Web of Science ®Google Scholar
• Muro FJ, Fiorillo SP, Sakasaka P, Odhiambo C, Reddy EA, Cunningham CK, Buchanan AM. Seroprevalence of hepatitis B and C viruses among children in Kilimanjaro Region, Tanzania. J Pediatric Inf Dis Soc. 2013;2:320–26. doi:10.1093/jpids/pit018.
   PubMedGoogle Scholar
• Mutwa PR, Boer KR, Rusine JB, Muganga N, Tuyishimire D, Reiss P, Lange JM, Geelen SPM. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda. Pediatr Inf Dis J. 2013;32:246–51.
   PubMed Web of Science ®Google Scholar
• Nwolisa E, Mbanefo F, Ezeogu J, Amadi P. Prevalence of hepatitis B co-infection amongst HIV infected children attending a care and treatment centre in Owerri, South-Eastern Nigeria. Pan Afr Med J. 2013;14:2–6. doi:10.11604/pamj.2013.14.89.1711.
   PubMedGoogle Scholar
• Sadoh AE, Sadoh WE. HIV co-infection with hepatitis B and C viruses among Nigerian children in an antiretroviral treatment programme. S Afr J Child Health. 2011;5:7–10.
   Google Scholar
• Telatela SP, Matee MI, Munubhi EK. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania. BMC Pub Health. 2007;7:1–6. doi:10.1186/1471-2458-7-338.
   PubMed Web of Science ®Google Scholar
• Varo R, Chris Buck W, Kazembe PN, Phiri S, Andrianarimanana D, Weigel R. Seroprevalence of CMV, HSV-2 and HBV among HIV-infected Malawian children: a cross-sectional survey. J Trop Pediatr. 2016;62:220–26. doi:10.1093/tropej/fmv105.
   PubMed Web of Science ®Google Scholar
• Moss WJ, Monze M, Ryon JJ, Quinn TC, Griffin DE, Cutts F. Prospective study of measles in hospitalized, Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Inf Dis. 2002;35:189–96. doi:10.1086/341248.
   PubMed Web of Science ®Google Scholar
• Wirth KE, Wolf ER, Goldfarb DM, Ho-Foster A, Tolle M, Jacovides C, Kirk B, Chise M, Steenhoff AP. Risk factors for measles in HIV-infected children and adolescents in Botswana. Pediatr Inf Dis J. 2015;34:1093–95. doi:10.1097/INF.0000000000000816.
   PubMed Web of Science ®Google Scholar
• Gill CJ, Mwananyanda L, Macleod W, Kwenda G, Mwale M, Williams AL, Siazeele K, Yang Z, Mwansa J, Thea DM. Incidence of severe and nonsevere pertussis among HIV-exposed and -unexposed Zambian infants through 14 weeks of age: results from the Southern Africa Mother Infant Pertussis Study (SAMIPS), a longitudinal birth cohort study. Clin Infect Dis. 2016;63:S154–S164. doi:10.1093/cid/ciw526.
   PubMed Web of Science ®Google Scholar
• Soofie N, Nunes MC, Kgagudi P, Van Niekerk N, Makgobo T, Agosti Y, Hwinya C, Pathirana J, Madhi SA. The burden of pertussis hospitalization in HIV-exposed and HIV-unexposed South African infants. Clin Infect Dis. 2016;63:S165–73. doi:10.1093/cid/ciw545.
   PubMed Web of Science ®Google Scholar
• Johnson S, Hendson W, Crewe-Brown H, Dini L, Frean J, Perovic O, Vardas E. Effect of human immunodeficiency virus infection on episodes of diarrhea among children in South Africa. Pediatr Inf Dis J. 2000;19:972–79. doi:10.1097/00006454-200010000-00007.
   PubMed Web of Science ®Google Scholar
• Moyo SJ, Blomberg B, Hanevik K, Kommedal O, Vainio K, Maselle SY, Langeland N. Genetic diversity of circulating rotavirus strains in Tanzania prior to the introduction of vaccination. PLoS One. 2014;9:1–10. doi:10.1371/journal.pone.0097562.
   Web of Science ®Google Scholar
• Ásbjörnsdóttir KH, Slyker JA, Maleche-Obimbo E, Wamalwa D, Otieno P, Gichuhi CM, John-Stewart G. Breastfeeding is associated with decreased risk of hospitalization among HIV-exposed, uninfected Kenyan infants. J Hum Lact. 2016;32:NP61–6. doi:10.1177/0890334415607854.
   PubMed Web of Science ®Google Scholar
• Nathoo KJ, Chigonde S, Nhembe M, Ali MH, Mason PR. Community-acquired bacteremia in human immunodeficiency virus-infected children in Harare, Zimbabwe. Pediatr Inf Dis J. 1996;15:1092–97. doi:10.1097/00006454-199612000-00007.
   PubMed Web of Science ®Google Scholar
• Zar HJ, Hanslo D, Tannenbaum E, Klein M, Argent A, Eley B, Burgess J, Magnus K, Bateman E, Hussey G. The etiology and outcome of pneumonia in human immunodeficiency virus-infected children admitted to intensive care in a developing country. Acta Paediatr. 2001;90:108–12.
   Google Scholar
• Jones N, Huebner R, Khoosal M, Crewe-Brown H, Klugman K. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS. 1998;12:2177–88. doi:10.1097/00002030-199816000-00013.
   PubMed Web of Science ®Google Scholar
• Roca A, Sigaúque B, Quintó L, Morais L, Berenguera A, Corachan M, Ribó JL, Naniche D, Bassat Q, Sacoor C, et al. Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children. Vaccine. 2010;28:4851–57. doi:10.1016/j.vaccine.2010.03.060.
   PubMed Web of Science ®Google Scholar
• Cohen C, Moyes J, Tempia S, Groome M, Walaza S, Pretorius M, Naby F, Mekgoe O, Kahn K, von Gottberg A, et al. Epidemiology of acute lower respiratory tract infection in HIV-exposed uninfected infants. Pediatrics. 2016;137:e20153272. doi:10.1542/peds.2015-3272.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Von Gottberg A, De Gouveia L, Cohen C, Moore DP, Klugman KP, Madhi SA. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS. 2011;25:453–62. doi:10.1097/QAD.0b013e328343443b.
   PubMed Web of Science ®Google Scholar
• von Mollendorf C, Tempia S, Von Gottberg A, Meiring S, Quan V, Feldman C, Cloete J, Madhi SA, O’Brien KL, Klugman KP, et al. Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa. PLoS One. 2017;12:e0179905. doi:10.1371/journal.pone.0179905.
   PubMed Web of Science ®Google Scholar
• von Gottberg A, Cohen C, de Gouveia L, Meiring S, Quan V, Whitelaw A, Crowther-Gibson P, Madhi SA, Whitney CG, Klugman KP. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. Vaccine. 2013;31:4200–08. doi:10.1016/j.vaccine.2013.04.077.
   PubMed Web of Science ®Google Scholar
• Nyasulu P, Cohen C, De Gouveia L, Feldman C, Klugman KP, von Gottberg A. Increased risk of death in Human Immunodeficiency Virus-infected children with pneumococcal meningitis in South Africa, 2003–2005. Pediatr Inf Dis J. 2011;30:1075–80. doi:10.1097/INF.0b013e31822cca05.
   PubMed Web of Science ®Google Scholar
• Rekha Banu VV, Poorana Ganga Devi NP, Swaminathan S. Childhood TB: global epidemiology and impact of HIV. Paediatr Respir Rev. 2007;2:99–106. doi:10.1016/j.prrv.2007.04.010.
   Google Scholar
• World Health Organization. WHO end TB strategy. Geneva, Switzerland: WHO; 2015.
   Google Scholar
• Fischer Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O’Brien KL, Campbell H, Black RE. Global burden of childhood pneumonia and diarrhoea. The Lancet. 2013;381:1405–16. doi:10.1016/S0140-6736(13)60222-6.
   PubMed Web of Science ®Google Scholar
• Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–19. doi:10.1016/j.vaccine.2011.12.116.
   PubMed Web of Science ®Google Scholar
• Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis. Nigerian J Clin Pract. 2015;18:163–72. doi:10.4103/1119-3077.151035.
   PubMed Web of Science ®Google Scholar
• Nunes MC, von Gottberg A, de Gouveia L, Cohen C, Kuwanda L, Karstaedt AS, Klugman KP, Madhi SA. Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program. PLoS One. 2011;6:e27929. doi:10.1371/journal.pone.0027929.
   PubMed Web of Science ®Google Scholar
• Muloiwa R, Dube FS, Nicol MP, Zar HJ, Hussey GD. Incidence and diagnosis of pertussis in South African children hospitalized with lower respiratory tract infection. Pediatr Inf Dis J. 2016;35:611–16. doi:10.1097/INF.0000000000001132.
   PubMed Web of Science ®Google Scholar
• UNAIDS. UNAIDS data 2017. Geneva, Switzerland: UNAIDS; 2017.
   Google Scholar
• GAVI. Annual progress report 2017. Geneva, Switzerland: GAVI; 2018.
   Google Scholar
• Gona P, Van Dyke RB, Williams PL, Dankner WM, Chernoff MC, Nachman SA, Seage GR. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296:292–300. doi:10.1001/jama.296.3.292.
   PubMed Web of Science ®Google Scholar
• Marais BJ, Rabie H, Schaaf SH, Cotton M. Common opportunistic infections in HIV infected infants and children Part 1 – respiratory infections. S Afr Fam Pract. 2006;48:52–56.
   Google Scholar
• Mutsaerts EAML, Nunes MC, van Rijswijk MN, Klipstein-Grobusch K, Grobbee DE, Madhi SA. Safety and immunogenicity of measles vaccination in HIV-infected and HIV-exposed uninfected children: a systematic review and meta-analysis. E Clin Med. 2018;1:28–42.
   Google Scholar
• Scott P, Moss WJ, Gilani Z, Low N. Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Inf Dis. 2011;204:S164–78. doi:10.1093/infdis/jir071.
   PubMed Web of Science ®Google Scholar
• Nachega JB, Uthman OA, Ho Y-S, Lo M, Anude C, Kayembe P, Wabwire-Mangen F, Gomo E, Sow PS, Obike U, et al. Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol. 2012;41:1829–46. doi:10.1093/ije/dys189.
   PubMed Web of Science ®Google Scholar
• Saxenian H, Hecht R, Kaddar M, Schmitt S, Ryckman T, Cornejo S. Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries. Health Policy Plan. 2015;30:197–205. doi:10.1093/heapol/czu003.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, Atkins D, Barbour V, Barrowman N, Berlin JA, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–69.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. Ottawa, Canada: Ottawa Hospital Research Institute; 2013.
   Google Scholar
• Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. UK: The Cochrane Collaboration; 2011.
   Google Scholar
• StataCorp. Stata Statistical Software: release 14. College Station (TX): StataCorp LP; 2015.
   Google Scholar
• Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual percent change in trend analysis. Stat Med. 2009;28:3670–82. doi:10.1002/sim.3733.
   PubMed Web of Science ®Google Scholar